Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Review

Histopathological evaluation of liver fibrosis and cirrhosis regression

Regina C. Lo, Haeryoung Kim

Clin Mol Hepatol. 2017;23(4):302-307. Published online December 20, 2017

DOI: https://doi.org/10.3350/cmh.2017.0078

View: 16863 Download: 552 Web of Science: 95 Crossref: 90

Case Report

Regression of esophageal varices and splenomegaly in two patients with hepatitis-C-related liver cirrhosis after interferon and ribavirin combination therapy

Soon Jae Lee, Yoo-Kyung Cho, Soo-Young Na, Eun Kwang Choi, Sun Jin Boo, Seung Uk Jeong, Hyung Joo Song, Heung Up Kim, Bong Soo Kim, Byung-Cheol Song

Clin Mol Hepatol. 2016;22(3):390-395. Published online August 30, 2016

DOI: https://doi.org/10.3350/cmh.2015.0050

View: 11223 Download: 132 Web of Science: 1 Crossref: 2

Editorial

Regression of liver cirrhosis: Orthodoxy or paradigm shift?

Su Jong Yu

Clin Mol Hepatol. 2015;21(1):22-23. Published online March 25, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.1.22

View: 6724 Download: 89 Web of Science: 2 Crossref: 1

4

A Case of Complete Regression of Hepatocellular Carcinoma during Administration of COX-2 Inhibitor

Hae Jung Song, M.D., Yun Soo Kim, M.D. Chang Hee Han, M.D., Jae Young Jang, M.D., Jung Hoon Kim, M.D. Young Koog Cheon, M.D., Young Seok Kim, M.D., Jong Ho Moon, M.D., Young Deok Cho, M.D., Chan Sup Shim, M.D., Kui Hyang Kwon, M.D. and Boo Sung Kim, M.D.

Clin Mol Hepatol. 2006;12(3):449-454. Published online January 1, 2000

View: 2728 Download: 19

1 |

Viewed By 5085	MAFLD: How is it different from NAFLD?
Viewed By 5072	Examining the therapeutic landscape of beta-blockers in portal hypertension
Viewed By 4496	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4470	Global incidence and prevalence of nonalcoholic fatty liver disease
Viewed By 4361	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma

Cited By 248	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 198	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 145	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 138	MAFLD: How is it different from NAFLD?
Cited By 113	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach

Search